Wegovy May Be Valuable New Option for Heart Failure Patients By Ernie Mundell HealthDay Reporter FRIDAY, Aug. 25, 2023 — Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing. Now, injected Wegovy could prove a boon for many patients battling heart failure, a […]
